At #SXSW2024 , our CMO Dr. John Rex joined a panel of #InfectiousDisease experts from CDC and Radboudumc to discuss the increasing threat of fungal infections, effects of climate change and more. Read in the Washington Examiner: brnw.ch/21wJ5mK #FungiForumSXSW SXSW

We are proud to sponsor the 68th Annual Coccidioidomycosis Study Group. We’ll have two oral and one poster presentation highlighting the progress our team and partners are making to address Coccidioidomycosis ( #ValleyFever ). To learn more, visit: brnw.ch/21wIy7q #Fungi

Attending #SXSW2024 ? Our Chief Medical Officer, Dr. John Rex, will join a dynamic panel of fungal disease experts on Monday, March 11 at 4pm CST in Austin, TX. Don’t miss out on this engaging discussion—add it to your calendar now! brnw.ch/21wHHVL SXSW #FungiForumSXSW

Attending #SXSW2024 ? Our Chief Medical Officer, Dr. John Rex, will join a dynamic panel of fungal disease experts on Monday, March 11 at 4pm CST in Austin, TX. Don’t miss out on this engaging discussion—add it to your calendar now! brnw.ch/21wHHtH SXSW #FungiForumSXSW

Join us at #SXSW2024 , where a panel of infectious disease experts from F2G, government, & academia will explore challenges posed by fungi, treatment complexities, cross-resistance, & shared DNA hurdles in antifungal dev't. Learn more: bit.ly/3T7nXHC SXSW #FungiForumSXSW

At F2G, we’re united by the belief that patients fighting rare life-threatening fungal infections need more options. Learn how we are harnessing the power of a novel science to advance an antifungal therapy by visiting our new website: brnw.ch/21wGLdo

We’re thrilled to announce the launch of the new F2G website. It tells our story of tenacity as we grow and navigate complex challenges to deliver a novel antifungal so that patients can have a fighting chance. Explore our new website by clicking here: brnw.ch/21wGynx

Our CMO, Dr. John Rex, joined industry experts in sharing insights on the threat posed by #FungalInfections and the need for innovative treatments to combat these diseases effectively in the latest InfectiousDiseaseSE. Read more: brnw.ch/21wF2lK #FireExtinguishersOfMedicine

Our Global Head of Medical Affairs, Dr. Emma Harvey was featured in BioPharma-Reporter’s “Women in Science” series. Dr. Harvey delves into her career journey, offering valuable insights & guidance for aspiring young women & carers in science. Read more: brnw.ch/21wERK3

Today, we presented the full data set from a Phase 2b study of our oral #antifungal in patients with invasive #fungalinfections who have limited or no treatment options at TIMM2023, Athens, Greece. Read press release here for more details: brnw.ch/21wDJDD

F2G is committed to making a difference in the #antifungal treatment landscape and is excited to be at the Trends in Medical Mycology (TIMM2023, Athens, Greece) 2023 Congress. We look forward to welcoming you to our booth #7 where you can learn more about F2G!

The TIMM2023, Athens, Greece kicks off today! We are excited to announce that 10 abstracts on our #antifungal candidate have been accepted. We look forward to engaging and sharing research findings with you. Check out the programme lineup here: brnw.ch/21wDHUj

We are pleased to sponsor TIMM2023, Athens, Greece. TIMM is one of the largest global forums in which scientists and clinicians from all over the world present their latest advances and research findings in medical mycology. Register at: brnw.ch/21wDGtq

We’re pleased to announce that F2G is a The Creative Floor Awards winner in the Best Exhibit (HCP) category for our IDWeek 2022 booth exhibit, 'The Fine Art of Fighting', in partnership with NEON and Poretta & Orr, Inc.. Visit our booth #508 at #IDWeek2023 to check out the exhibit.

Today’s #FungalDiseaseAwarenessWeek theme highlights the impact of climate change on fungal diseases. #ValleyFever is on the rise in the U.S., and climate change could be helping spread the fungus. Learn more about the connection between the two: brnw.ch/21wCQ78  #FDAW

Today’s #FungalDiseaseAwarenessWeek theme is ‘The Path of Yeast Resistance’. A leading cause of antifungal resistance in molds is the use of fungicides in agriculture because they are often structurally related. Learn more in this nature article: brnw.ch/21wBHJs  #FDAW

Today marks the beginning of #FungalDiseaseAwarenessWeek . As part of #FDAW , the CDC is partnering with the World Health Organization (WHO) for a webinar covering a global view on the challenges and opportunities of #FungalDiseases . Click for webinar details: brnw.ch/21wCGAF

Check out this recent article by Dominique Mosbergen in the The Wall Street Journal discussing the rise in drug-resistant #fungalinfections , challenges developing new antifungal drugs, and the need to preserve their efficacy. Read the full article here: brnw.ch/21wCacp

August is #ValleyFever Awareness Month in California. You get Valley Fever by inhaling microscopic fungal spores from Coccidioides in the air. In 2019, there were >20,000 cases reported to the CDC. Learn more here: brnw.ch/21wC8xX

Check out this WIRED article featuring Dr. John Rex and Dr. Emma Harvey discussing a novel mechanism for killing fungi shared by an investigational pharmaceutical and agricultural compound, and its potential threat of cross-resistance to human health: brnw.ch/21wC5oK